BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15824155)

  • 1. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
    Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women.
    Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):750-5. PubMed ID: 16614119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
    Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
    Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
    Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
    Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
    Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
    Cancer Res; 2007 Aug; 67(16):7923-8. PubMed ID: 17699799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of insulin-like growth factor 1, its binding protein 3, and risk of endometriosis.
    Mu F; Hankinson SE; Schernhammer E; Pollak MN; Missmer SA
    Am J Epidemiol; 2015 Jul; 182(2):148-56. PubMed ID: 26121987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
    Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
    Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
    Jiang B; Liu DB; Zhang X; DU LL; Han CZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
    Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
    Kaczka A; Kumor A; Pietruczuk M; MaƂecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I and binding protein-3 and risk of cancer.
    Giovannucci E
    Horm Res; 1999; 51 Suppl 3():34-41. PubMed ID: 10592442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.
    Palmqvist R; Stattin P; Rinaldi S; Biessy C; Stenling R; Riboli E; Hallmans G; Kaaks R
    Int J Cancer; 2003 Oct; 107(1):89-93. PubMed ID: 12925961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.